Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $115,371 | 15 | 98.8% |
| Travel and Lodging | $1,206 | 3 | 1.0% |
| Food and Beverage | $187.69 | 3 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc. | $115,371 | 15 | $0 (2017) |
| Theravance Biopharma Inc. | $1,336 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.00 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $28.35 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $30.00 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30.00) |
| 2021 | $28.35 | 1 | Sunovion Pharmaceuticals Inc. ($28.35) |
| 2017 | $116,707 | 19 | Glenmark Pharmaceuticals Inc. ($115,371) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.00 | General |
| 06/09/2021 | Sunovion Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $28.35 | General |
| 11/09/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $11,027.10 | Research |
| Study: GSP304-201 | ||||||
| 10/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $63,122.85 | Research |
| Study: GSP304-201 | ||||||
| 09/28/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $4,237.00 | Research |
| Study: GSP304-201 | ||||||
| 07/20/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $36,121.05 | Research |
| Study: GSP304-201 | ||||||
| 06/28/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $44.95 | Research |
| Study: GSP304-201 | ||||||
| 06/13/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $19.06 | Research |
| Study: GSP304-201 | ||||||
| 06/13/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $7.71 | Research |
| Study: GSP304-201 | ||||||
| 05/31/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $500.00 | Research |
| Study: GSP304-201 | ||||||
| 05/31/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $38.12 | Research |
| Study: GSP304-201 | ||||||
| 05/31/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $8.99 | Research |
| Study: GSP304-201 | ||||||
| 04/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $200.00 | Research |
| Study: GSP304-201 | ||||||
| 04/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $19.06 | Research |
| Study: GSP304-201 | ||||||
| 04/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $17.98 | Research |
| Study: GSP304-201 | ||||||
| 04/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $7.06 | Research |
| Study: GSP304-201 | ||||||
| 04/26/2017 | Glenmark Pharmaceuticals Inc. | — | — | Cash or cash equivalent | $0.40 | Research |
| Study: GSP304-201 | ||||||
| 03/12/2017 | Theravance Biopharma Inc. | — | Travel and Lodging | Cash or cash equivalent | $8.39 | General |
| 03/11/2017 | Theravance Biopharma Inc. | — | Travel and Lodging | Cash or cash equivalent | $235.27 | General |
| 03/11/2017 | Theravance Biopharma Inc. | — | Food and Beverage | Cash or cash equivalent | $129.34 | General |
| 03/10/2017 | Theravance Biopharma Inc. | — | Travel and Lodging | Cash or cash equivalent | $962.67 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP304-201 | Glenmark Pharmaceuticals Inc. | $115,371 | 15 |
About Dr. Orlando Rivero, MD
Dr. Orlando Rivero, MD is a General Practice healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2011. The National Provider Identifier (NPI) number assigned to this provider is 1699056572.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Orlando Rivero, MD has received a total of $116,765 in payments from pharmaceutical and medical device companies, with $30.00 received in 2023. These payments were reported across 21 transactions from 4 companies. The most common payment nature is "" ($115,371).
Practice Information
- Specialty General Practice
- Other Specialties General Practice, General Practice
- Location Miami, FL
- Active Since 09/06/2011
- Last Updated 01/25/2023
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699056572
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Miami
Dr. Rafael Gonzalez, M.d, M.D
General Practice — Payments: $727,118
Dr. Jose Cardona, M.d, M.D
General Practice — Payments: $177,395
Idalia Acosta, M.d, M.D
General Practice — Payments: $132,449
Omar Benitez, Md, MD
General Practice — Payments: $123,017
Lilia Rodriguez Ables, Md, MD
General Practice — Payments: $100,020
Mrs. Silvia Silva Duluc, M.d, M.D
General Practice — Payments: $56,981